Innovative MedTech Inc. (IMTH)
USD 0.45
(0.0%)
USD 0.45
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -7.93 Million USD | -117.63% |
| 2023 | -3.64 Million USD | 79.56% |
| 2022 | -17.84 Million USD | -400.09% |
| 2021 | -3.56 Million USD | -411.28% |
| 2020 | -698.04 Thousand USD | -95.19% |
| 2019 | -357.62 Thousand USD | 0.0% |
| 2014 | -365.34 Thousand USD | 35.55% |
| 2013 | -566.85 Thousand USD | 61.92% |
| 2012 | -1.48 Million USD | -42.15% |
| 2011 | -1.04 Million USD | 48.05% |
| 2010 | -2.01 Million USD | -166.45% |
| 2009 | -756.42 Thousand USD | 44.5% |
| 2008 | -1.36 Million USD | -28.98% |
| 2007 | -1.05 Million USD | -2.72% |
| 2006 | -1.02 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -6.67 Million USD | -633.71% |
| 2024 Q3 | -909.87 Thousand USD | -383.6% |
| 2024 Q2 | -188.14 Thousand USD | -13.98% |
| 2024 Q1 | -165.06 Thousand USD | 81.04% |
| 2023 Q2 | -966.91 Thousand USD | 1.59% |
| 2023 Q1 | -982.51 Thousand USD | 94.44% |
| 2023 FY | -3.64 Million USD | 79.56% |
| 2023 Q4 | -870.79 Thousand USD | -22.07% |
| 2023 Q3 | -713.33 Thousand USD | 26.23% |
| 2022 FY | -17.84 Million USD | -400.09% |
| 2022 Q4 | -17.67 Million USD | -4860.41% |
| 2022 Q3 | 371.36 Thousand USD | 286.75% |
| 2022 Q2 | -198.85 Thousand USD | 23.32% |
| 2022 Q1 | -259.31 Thousand USD | 63.35% |
| 2021 Q1 | -230.46 Thousand USD | 0.0% |
| 2021 Q4 | -707.6 Thousand USD | 67.35% |
| 2021 Q2 | -159.94 Thousand USD | 30.6% |
| 2021 Q3 | -2.16 Million USD | -1255.18% |
| 2021 FY | -3.56 Million USD | -411.28% |
| 2020 FY | -698.04 Thousand USD | -95.19% |
| 2019 FY | -357.62 Thousand USD | 0.0% |
| 2015 Q1 | -348.38 Thousand USD | -221.98% |
| 2014 Q1 | -53.88 Thousand USD | -233.56% |
| 2014 Q4 | 285.6 Thousand USD | 354.45% |
| 2014 Q3 | -112.24 Thousand USD | 41.03% |
| 2014 FY | -365.34 Thousand USD | 35.55% |
| 2014 Q2 | -190.32 Thousand USD | -253.2% |
| 2013 FY | -566.85 Thousand USD | 61.92% |
| 2013 Q4 | -16.15 Thousand USD | 94.6% |
| 2013 Q1 | -983.62 Thousand USD | -443.45% |
| 2013 Q2 | -197.43 Thousand USD | 79.93% |
| 2013 Q3 | -299.38 Thousand USD | -51.63% |
| 2012 Q2 | -133.47 Thousand USD | 66.44% |
| 2012 FY | -1.48 Million USD | -42.15% |
| 2012 Q4 | -180.99 Thousand USD | 4.93% |
| 2012 Q3 | -190.38 Thousand USD | -42.64% |
| 2012 Q1 | -397.69 Thousand USD | -1072.35% |
| 2011 Q1 | -1.23 Million USD | -253.29% |
| 2011 FY | -1.04 Million USD | 48.05% |
| 2011 Q4 | 40.9 Thousand USD | 110.16% |
| 2011 Q3 | -402.51 Thousand USD | -39.86% |
| 2011 Q2 | -287.79 Thousand USD | 76.71% |
| 2010 FY | -2.01 Million USD | -166.45% |
| 2010 Q1 | -184.78 Thousand USD | -46.05% |
| 2010 Q2 | -170.81 Thousand USD | 7.56% |
| 2010 Q3 | -214.82 Thousand USD | -25.76% |
| 2010 Q4 | -349.78 Thousand USD | -62.82% |
| 2009 Q1 | -264.89 Thousand USD | 35.1% |
| 2009 Q4 | -126.52 Thousand USD | 59.54% |
| 2009 Q3 | -312.72 Thousand USD | -103.62% |
| 2009 Q2 | -153.58 Thousand USD | 42.02% |
| 2009 FY | -756.42 Thousand USD | 44.5% |
| 2008 Q2 | -465.6 Thousand USD | -30.4% |
| 2008 Q1 | -357.05 Thousand USD | -5.29% |
| 2008 Q3 | -224.28 Thousand USD | 51.83% |
| 2008 Q4 | -408.18 Thousand USD | -81.99% |
| 2008 FY | -1.36 Million USD | -28.98% |
| 2007 Q3 | -142.47 Thousand USD | 34.68% |
| 2007 Q4 | -339.1 Thousand USD | -138.01% |
| 2007 FY | -1.05 Million USD | -2.72% |
| 2007 Q1 | -91.39 Thousand USD | 2.65% |
| 2007 Q2 | -218.12 Thousand USD | -138.65% |
| 2006 Q3 | -344.39 Thousand USD | 35.09% |
| 2006 Q2 | -530.58 Thousand USD | 0.0% |
| 2006 Q4 | -93.88 Thousand USD | 72.74% |
| 2006 FY | -1.02 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | -756.506% |
| Ansell Limited | 76.5 Million USD | 110.378% |
| Ansell Limited | 76.5 Million USD | 110.378% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 132.697% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | -386.976% |
| Psykey, Inc. | -1.32 Million USD | -499.637% |
| ConvaTec Group Plc | 130.3 Million USD | 106.093% |
| ConvaTec Group Plc | 130.3 Million USD | 106.093% |
| Encision Inc. | -691.78 Thousand USD | -1047.599% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -5498.224% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -3287.393% |
| LifePoint, Inc. | -15.23 Million USD | 47.879% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | -16.56% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | -1574.873% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -2792.699% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | -1629.502% |
| SmileDirectClub, Inc. | -86.4 Million USD | 90.812% |
| Sector 10, Inc. | 7036.00 USD | 112932.533% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.397% |
| SheerVision, Inc. | -71.37 Thousand USD | -11022.642% |
| United Health Products, Inc. | -2.62 Million USD | -202.634% |
| Vasamed, Inc. | -4.88 Million USD | -62.411% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | -232.385% |
| Yubo International Biotech Limited | -1.2 Million USD | -558.958% |